1-7 of 7
Keywords: Type II diabetes mellitus
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Clin Sci (Lond) (2005) 108 (2): 93–99.
Published: 21 January 2005
... associated with Type II diabetes mellitus [ 35 ] through sustained overactivation of the cardiac sympathetic nervous system. Over the past decade, evidence has been accumulated indicating a double mechanism of action of insulin: a central neural action and a peripheral action. Insulin crosses the blood–brain...
Clin Sci (Lond) (2003) 105 (1): 59–66.
Published: 01 July 2003
... tissue Doppler Type II diabetes mellitus Clinical Science (2003) 105, 59 66 (Printed in Great Britain) 59 Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study...
Clin Sci (Lond) (2003) 105 (1): 113–118.
Published: 01 July 2003
... reactivity C-peptide endothelial function glucagon test homoeostasis model assessment (HOMA) index Type II diabetes mellitus Clinical Science (2003) 105, 113 118 (Printed in Great Britain) 113 Residual C-peptide secretion and endothelial function in patients with Type II diabetes Daniela MANZELLA...
Clin Sci (Lond) (2002) 102 (3): 307–314.
Published: 08 February 2002
...% respectively; P < 0.0005). Forearm blood flow responses to acetylcholine, dipyridamole and forearm ischaemia were similar during glibenclamide and acarbose treatment. Thus, in patients with Type II diabetes mellitus, treatment with glibenclamide is associated with an attenuated response to K ATP opening...
Clin Sci (Lond) (2001) 101 (1): 29–35.
Published: 23 May 2001
...C. RUSTEMEIJER; J. A. SCHOUTEN; H. J. VOERMAN; A. C. BEYNEN; A. J. M. DONKER; R. J. HEINE Hypertriglyceridaemia is a risk factor for cardiovascular disease in patients suffering from Type II diabetes mellitus, and is due to enhanced synthesis and/or impaired clearance of triacylglycerol-rich...
Clin Sci (Lond) (2000) 99 (1): 89–90.
Published: 21 June 2000
... ). 27 10 1999 The Biochemical Society and the Medical Research Society © 2000 2000 obesity pharmacogenetics point mutation type II diabetes mellitus transcription factors 89Clinical Science (2000) 99, 89 90 (Printed in Great Britain) + C O R R E S P O N D E N C E The Pro-115!Gln...
Clin Sci (Lond) (1998) 95 (3): 325–329.
Published: 01 September 1998
...) amide incretin treatment Type II diabetes mellitus 325Clinical Science (1998) 95, 325 329 (Printed in Great Britain) Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early Type 2 diabetes Jeannie F. TODD, C. Mark B. EDWARDS...